Skip to main content
SpringerLink
Log in

The case for cardiac magnetic resonance and positron emission tomography multimodality imaging of myocardial viability

  • Editor's Page
  • Published:
Journal of Nuclear Cardiology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Schinkel AFL, Poldermans D, Elhendy A, Bax J. Assessment of myocardial viability in patients with heart failure. J Nucl Med 2007;48:1135-46.

    Article  PubMed  Google Scholar 

  2. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and severe left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151-8.

    Article  PubMed  Google Scholar 

  3. Abraham A, Nichol G, Williams KA, Guo A, deKemp RA, Garrard L, et al. 18F-FDG PET imaging of myocardial viability in an experienced center with access to 18FDG and integration with clinical management teams: The Ottawa-FIVE substudy of the PARR 2 trial. J Nucl Med 2010;51:567-74.

    Article  PubMed  Google Scholar 

  4. Hage FG, Venkataraman R, Aljaroudi W, Bravo PE, McLarry J, Faulkner M, et al. The impact of viability assessment using myocardial perfusion imaging on patient management and outcome. J Nucl Cardiol 2010;17:378-89.

    Article  PubMed  Google Scholar 

  5. Kim RJ, Wu E, Rafael A, Chen E-L, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.

    Article  CAS  PubMed  Google Scholar 

  6. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, et al. Contrast-enhanced MRI and routine single photon emission tomography (SPECT) perfusion imaging for detection of subendocardial infarcts: An imaging study. Lancet 2003;361:374-79.

    Article  PubMed  Google Scholar 

  7. Maddahi J. Viability assessment with MRI is superior to FDG-PET for viability: Pro. J Nucl Cardiol 2010;17:292-7.

    Article  PubMed  Google Scholar 

  8. Patterson RE, Sigman SR, O’Donnell RE, Eisner RL. Viability assessment with MRI is superior to FDG PET for viability: Con. J Nucl Cardiol 2010;17:298-309.

    Article  PubMed  Google Scholar 

  9. De Winter O, Van de Veire N, Van Heuversqijn F, Van Pottelberge G, Gillebert TC, De Sutter J. Relationship between QRS duration, left ventricular volumes and prevalence of nonviability in patients with coronary artery disease and severe left ventricular dysfunction. Eur J Heart Fail 2006;8:275-7.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. George A. Beller MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beller, G.A. The case for cardiac magnetic resonance and positron emission tomography multimodality imaging of myocardial viability. J. Nucl. Cardiol. 17, 527–528 (2010). https://doi.org/10.1007/s12350-010-9270-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-010-9270-y

Search

Navigation